2024
DOI: 10.1016/j.bbagen.2023.130503
|View full text |Cite
|
Sign up to set email alerts
|

Tyrosinase inhibitory peptides: Structure-activity relationship study on peptide chemical properties, terminal preferences and intracellular regulation of melanogenesis signaling pathways

Pei-Gee Yap,
Chee-Yuen Gan
Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(2 citation statements)
references
References 48 publications
0
2
0
Order By: Relevance
“…On the other hand, the potency to inhibit tyrosinase activity of the cantaloupe juice-treated hydrolysate is similar to that of the bromelain-treated one despite the fact that cantaloupe juice generated a lower DH value than bromelain. The differences in the anti-tyrosinase activity of EBN hydrolysates might be caused by the levels of free sialic acid or the properties of bioactive peptides (hydrophobicity, amino acid type, and the arrangement of terminal amino acid residues) in the hydrolysates [ 48 ].…”
Section: Resultsmentioning
confidence: 99%
“…On the other hand, the potency to inhibit tyrosinase activity of the cantaloupe juice-treated hydrolysate is similar to that of the bromelain-treated one despite the fact that cantaloupe juice generated a lower DH value than bromelain. The differences in the anti-tyrosinase activity of EBN hydrolysates might be caused by the levels of free sialic acid or the properties of bioactive peptides (hydrophobicity, amino acid type, and the arrangement of terminal amino acid residues) in the hydrolysates [ 48 ].…”
Section: Resultsmentioning
confidence: 99%
“…Thus, inhibition of melanogenesis represents a realistic adjuvant strategy to amplify existing therapeutic approaches ( Figure 1 ) [ 4 , 235 , 367 , 393 ]. In this context, it is worth mentioning that a diverse range of non-toxic inhibitors of tyrosinase activity are available [ 292 , 394 , 395 , 396 ], which in addition to copper chelators (cofactor for tyrosinase) would inhibit tyrosinase and decrease melanin synthesis [ 365 , 367 , 371 , 373 , 397 , 398 , 399 , 400 ]. However, we acknowledge that others, including some of us, have proposed using the melanogenic pathway as a tool for melanoma therapy utilizing the cytotoxicity of melanogenesis products [ 248 , 377 , 380 , 401 , 402 ], also reviewed in [ 4 ].…”
Section: Melanin Melanogenesis and Solar Radiation In A “Nutshell”mentioning
confidence: 99%